[
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified_and_ERBB2_unspecified",
        "aa_mutation":"unspecified_and_ERBB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified_or_BRCA2_unspecified",
        "aa_mutation":"unspecified_or_BRCA2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Triple-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified_or_BRCA2_unspecified",
        "aa_mutation":"unspecified_or_BRCA2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified_or_BRCA2_unspecified",
        "aa_mutation":"unspecified_or_BRCA2_unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified_or_BRCA2_unspecified_or_PALB2_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
        "aa_mutation":"unspecified_or_BRCA2_unspecified_or_PALB2_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified_or_BRCA2_unspecified_or_PALB2_unspecified",
        "aa_mutation":"unspecified_or_BRCA2_unspecified_or_PALB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified_or_BRCA2_unspecified_or_CHEK2_unspecified_or_PALB2_unspecified",
        "aa_mutation":"unspecified_or_BRCA2_unspecified_or_CHEK2_unspecified_or_PALB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Her2-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"Loss-of-function",
        "aa_mutation":"Loss-of-function",
        "disease":"Her2-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"Loss-of-function",
        "aa_mutation":"Loss-of-function",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Triple-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05485766"
    },
    {
        "gene_name":"AKT2",
        "genomic_position":"19:40736224-40791302(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22842582"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_WT1_unspecified",
        "aa_mutation":"unspecified_and_WT1_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_(PIK3CA_Exon9_or_PIK3CA_Exon20)_",
        "aa_mutation":"unspecified_and_(PIK3CA_Exon9_or_PIK3CA_Exon20)_",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_ESR1_unspecified",
        "aa_mutation":"unspecified_and_ESR1_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_GATA3_unspecified",
        "aa_mutation":"unspecified_and_GATA3_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_PIK3CA_unspecified",
        "aa_mutation":"unspecified_and_PIK3CA_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_PTEN_unspecified",
        "aa_mutation":"unspecified_and_PTEN_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_TBX3_unspecified",
        "aa_mutation":"unspecified_and_TBX3_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_TOP2A_unspecified",
        "aa_mutation":"unspecified_and_TOP2A_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_TP53_unspecified",
        "aa_mutation":"unspecified_and_TP53_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_TP53_unspecified_",
        "aa_mutation":"unspecified_and_TP53_unspecified_",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"SERUM_LEVELS",
        "aa_mutation":"SERUM_LEVELS",
        "disease":"Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_ERBB2_unspecified",
        "aa_mutation":"unspecified_and_ERBB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"Exon19,Exon20",
        "aa_mutation":"Exon19,Exon20",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_NRG1_unspecified",
        "aa_mutation":"unspecified_and_NRG1_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_ERBB3_unspecified",
        "aa_mutation":"unspecified_and_ERBB3_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified_and_PIK3CA_unspecified",
        "aa_mutation":"unspecified_and_PIK3CA_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma in situ | ductal carcinoma in situ",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"c.2516T>G",
        "aa_mutation":"p.L839R",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"c.2606T>G",
        "aa_mutation":"p.L869R",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"c.1778T>G",
        "aa_mutation":"p.L593R",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"c.2561T>G",
        "aa_mutation":"p.L854R",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31867841"
    },
    {
        "gene_name":"RB1",
        "genomic_position":"13:48877911-49056122(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Alpelisib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25002028"
    },
    {
        "gene_name":"RB1",
        "genomic_position":"13:48877911-49056122(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Alpelisib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25002028"
    },
    {
        "gene_name":"RB1",
        "genomic_position":"13:48877911-49056122(+)",
        "cds_mutation":"PHOSPHORYLATION",
        "aa_mutation":"p.PHOSPHORYLATION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Alpelisib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25002028"
    },
    {
        "gene_name":"NF2",
        "genomic_position":"22:29999547-30094587(+)",
        "cds_mutation":"K159fs",
        "aa_mutation":"p.K159fs",
        "disease":"Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Temsirolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25878190"
    },
    {
        "gene_name":"GK",
        "genomic_position":"X:30671476-30748725(+)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Alpelisib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27451907"
    },
    {
        "gene_name":"IGF1",
        "genomic_position":"12:102811269-102874341(-)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Metformin,Exemestane",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26706833"
    },
    {
        "gene_name":"IGF1R",
        "genomic_position":"15:99192200-99507759(+)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Metformin,Exemestane",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26706833"
    },
    {
        "gene_name":"TUBB3",
        "genomic_position":"16:89989687-90002505(+)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Taxane Compound",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23218766"
    },
    {
        "gene_name":"CCND1",
        "genomic_position":"11:69455855-69469242(+)",
        "cds_mutation":"unspecified_or_CCND2_unspecified",
        "aa_mutation":"unspecified_or_CCND2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Eribulin",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04683445"
    },
    {
        "gene_name":"CCND1",
        "genomic_position":"11:69455855-69469242(+)",
        "cds_mutation":"unspecified_or_CDKN2A_unspecified_or_CDK4_unspecified_or_CDK6_unspecified",
        "aa_mutation":"unspecified_or_CDKN2A_unspecified_or_CDK4_unspecified_or_CDK6_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Eribulin",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04683445"
    },
    {
        "gene_name":"CCND1",
        "genomic_position":"11:69455855-69469242(+)",
        "cds_mutation":"unspecified_or_ESR1_unspecified_or_PGR_unspecified",
        "aa_mutation":"unspecified_or_ESR1_unspecified_or_PGR_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Eribulin",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04683445"
    },
    {
        "gene_name":"CCND1",
        "genomic_position":"11:69455855-69469242(+)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Estrogen-receptor Positive Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Eribulin",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04683445"
    },
    {
        "gene_name":"CCND1",
        "genomic_position":"11:69455855-69469242(+)",
        "cds_mutation":"unspecified_or_CDKN2A_unspecified_or_ESR1_unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified_or_TP53_unspecified_or_RB1_unspecified",
        "aa_mutation":"unspecified_or_CDKN2A_unspecified_or_ESR1_unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified_or_TP53_unspecified_or_RB1_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Eribulin",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04683445"
    },
    {
        "gene_name":"CCND1",
        "genomic_position":"11:69455855-69469242(+)",
        "cds_mutation":"unspecified_or_ERBB2_unspecified_or_ERBB4_unspecified_or_PIK3CA_unspecified_or_TP53_unspecified",
        "aa_mutation":"unspecified_or_ERBB2_unspecified_or_ERBB4_unspecified_or_PIK3CA_unspecified_or_TP53_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Eribulin",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04683445"
    },
    {
        "gene_name":"FOXP3",
        "genomic_position":"X:49106897-49121288(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Epirubicin",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22431701"
    },
    {
        "gene_name":"TFF3",
        "genomic_position":"21:43731777-43735761(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Aminoglutethimide,Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25900183"
    },
    {
        "gene_name":"BIRC5",
        "genomic_position":"17:76210267-76221717(+)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23204226"
    },
    {
        "gene_name":"UBB",
        "genomic_position":"17:16284113-16286054(+)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Taxane Compound",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23218766"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified_or_FGFR4_unspecified",
        "aa_mutation":"unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified_or_FGFR4_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified",
        "aa_mutation":"unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified_or_FGFR4_unspecified",
        "aa_mutation":"unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified_or_FGFR4_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"c.1608C>A",
        "aa_mutation":"p.N536K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"c.1365C>A",
        "aa_mutation":"p.N455K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"c.1632C>A",
        "aa_mutation":"p.N544K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"c.1731C>A",
        "aa_mutation":"p.N577K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"c.1371C>A",
        "aa_mutation":"p.N457K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"c.*688C>A",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"c.1638C>A",
        "aa_mutation":"p.N546K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"c.*533C>A",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30914635"
    },
    {
        "gene_name":"CA1",
        "genomic_position":"8:86239837-86291243(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Triple-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"CA1",
        "genomic_position":"8:86239837-86291243(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Triple-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"CA1",
        "genomic_position":"8:86239837-86291243(-)",
        "cds_mutation":"Loss-of-function",
        "aa_mutation":"Loss-of-function",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"CA1",
        "genomic_position":"8:86239837-86291243(-)",
        "cds_mutation":"Loss-of-function",
        "aa_mutation":"Loss-of-function",
        "disease":"Her2-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"CA1",
        "genomic_position":"8:86239837-86291243(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Her2-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"IK",
        "genomic_position":"5:140027355-140042063(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"IK",
        "genomic_position":"5:140027355-140042063(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"IK",
        "genomic_position":"5:140027355-140042063(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"IK",
        "genomic_position":"5:140027355-140042063(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"IK",
        "genomic_position":"5:140027355-140042063(+)",
        "cds_mutation":"c.1624G>A",
        "aa_mutation":"p.E542K",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"IK",
        "genomic_position":"5:140027355-140042063(+)",
        "cds_mutation":"H1047X",
        "aa_mutation":"p.H1047X",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"IK",
        "genomic_position":"5:140027355-140042063(+)",
        "cds_mutation":"c.1634A>G",
        "aa_mutation":"p.E545",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"IK",
        "genomic_position":"5:140027355-140042063(+)",
        "cds_mutation":"c.3140A>G",
        "aa_mutation":"p.H1047R",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"TUBB",
        "genomic_position":"6:30687978-30693203(+)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Taxane Compound",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23218766"
    },
    {
        "gene_name":"SF1",
        "genomic_position":"11:64532078-64545941(-)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:24367492"
    },
    {
        "gene_name":"FGF3",
        "genomic_position":"11:69624992-69633792(-)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Dovitinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23658459"
    },
    {
        "gene_name":"CDKN2A",
        "genomic_position":"9:21968055-21974865(-)",
        "cds_mutation":"Loss",
        "aa_mutation":"Loss",
        "disease":"Her2-receptor Negative Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Letrozole,Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26715889"
    },
    {
        "gene_name":"TIMP1",
        "genomic_position":"X:47441712-47446188(+)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Paclitaxel",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22544540"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"unspecified_or_PTEN_unspecified_or_TP53_unspecified",
        "aa_mutation":"unspecified_or_PTEN_unspecified_or_TP53_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"c.3140A>G",
        "aa_mutation":"p.H1047R",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":121913279.0,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"c.1634A>G",
        "aa_mutation":"p.E545",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":121913274.0,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"H1047X",
        "aa_mutation":"p.H1047X",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"c.1624G>A",
        "aa_mutation":"p.E542K",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":121913273.0,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"unspecified_or_PTEN_unspecified",
        "aa_mutation":"unspecified_or_PTEN_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"Exon9_or_PIK3CA_Exon20",
        "aa_mutation":"Exon9_or_PIK3CA_Exon20",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PIK3CA",
        "genomic_position":"3:178866311-178957881(+)",
        "cds_mutation":"c.3140A>G",
        "aa_mutation":"p.H1047R",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant,Everolimus",
        "description":null,
        "rs_value":121913279.0,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"SGK1",
        "genomic_position":"6:134490384-134639196(-)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Alpelisib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27451907"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"c.745A>T",
        "aa_mutation":"p.R249",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":587782082.0,
        "pmid":"PubMed:10786679"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"DNA_Binding_Domain_Mutation",
        "aa_mutation":"DNA_Binding_Domain_Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:10786679"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"deletion_and_PDCD4_unspecified",
        "aa_mutation":"deletion_and_PDCD4_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:10786679"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:10786679"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:10786679"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Resistance",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:10786679"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | ER-positive carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*485A>C",
        "aa_mutation":"p.?",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.827A>C",
        "aa_mutation":"p.Y276S",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26478A>C",
        "aa_mutation":"p.?",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1610A>C",
        "aa_mutation":"p.Y537S",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26478A>C",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1610A>C",
        "aa_mutation":"p.Y537S",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*485A>C",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.827A>C",
        "aa_mutation":"p.Y276S",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*485A>C",
        "aa_mutation":"p.?",
        "disease":"lobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.827A>C",
        "aa_mutation":"p.Y276S",
        "disease":"lobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1610A>C",
        "aa_mutation":"p.Y537S",
        "disease":"lobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26478A>C",
        "aa_mutation":"p.?",
        "disease":"lobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.Y537C",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.Y537S",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1607T>A",
        "aa_mutation":"p.L536H",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1613A>G",
        "aa_mutation":"p.D538G",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.830A>G",
        "aa_mutation":"p.D277G",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.824T>A",
        "aa_mutation":"p.L275H",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*488A>G",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26475A>G",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*482T>A",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26481T>A",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26478A>G",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.827A>G",
        "aa_mutation":"p.Y276C",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1610A>G",
        "aa_mutation":"p.Y537C",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*485A>G",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1609T>A",
        "aa_mutation":"p.Y537N",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26479T>A",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.826T>A",
        "aa_mutation":"p.Y276N",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*484T>A",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1610A>C",
        "aa_mutation":"p.Y537S",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.827A>C",
        "aa_mutation":"p.Y276S",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*485A>C",
        "aa_mutation":"p.?",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26478A>C",
        "aa_mutation":"p.?",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26475A>G",
        "aa_mutation":"p.?",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1613A>G",
        "aa_mutation":"p.D538G",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.830A>G",
        "aa_mutation":"p.D277G",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*488A>G",
        "aa_mutation":"p.?",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.D538G",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.851-26481",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1607",
        "aa_mutation":"p.L536Q",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*482",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.824",
        "aa_mutation":"p.L275Q",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"(AA)\/",
        "aa_mutation":"p.L536",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.Y537N",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.*111-49294G>C",
        "aa_mutation":"p.?",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.1138G>C",
        "aa_mutation":"p.E380Q",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.42+67448G>C",
        "aa_mutation":"p.?",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.619G>C",
        "aa_mutation":"p.E207Q",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.453-49294G>C",
        "aa_mutation":"p.?",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"ESR1",
        "genomic_position":"6:152011631-152424409(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.Y537S",
        "disease":"ductal_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26434753"
    },
    {
        "gene_name":"PTEN",
        "genomic_position":"10:89622870-89731687(+)",
        "cds_mutation":"Loss",
        "aa_mutation":"Loss",
        "disease":"Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Everolimus,Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PTEN",
        "genomic_position":"10:89622870-89731687(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Everolimus,Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PTEN",
        "genomic_position":"10:89622870-89731687(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Everolimus,Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PTEN",
        "genomic_position":"10:89622870-89731687(+)",
        "cds_mutation":"Loss",
        "aa_mutation":"Loss",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Everolimus,Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PTEN",
        "genomic_position":"10:89622870-89731687(+)",
        "cds_mutation":"Expression",
        "aa_mutation":"Expression",
        "disease":"Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Everolimus,Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PTEN",
        "genomic_position":"10:89622870-89731687(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Everolimus,Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PTEN",
        "genomic_position":"10:89622870-89731687(+)",
        "cds_mutation":"Loss",
        "aa_mutation":"Loss",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Everolimus,Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"PTEN",
        "genomic_position":"10:89622870-89731687(+)",
        "cds_mutation":"Expression",
        "aa_mutation":"Expression",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Resistance",
        "therapies":"Everolimus,Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27445490"
    },
    {
        "gene_name":"SI",
        "genomic_position":"3:164696686-164796283(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Epirubicin",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22431701"
    },
    {
        "gene_name":"SI",
        "genomic_position":"3:164696686-164796283(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Epirubicin",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22431701"
    },
    {
        "gene_name":"SI",
        "genomic_position":"3:164696686-164796283(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Epirubicin",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22431701"
    },
    {
        "gene_name":"TUB",
        "genomic_position":"11:8060180-8127659(+)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Taxane Compound",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23218766"
    },
    {
        "gene_name":"NTRK3",
        "genomic_position":"15:88420022-88799661(-)",
        "cds_mutation":"ETV6::NTRK3",
        "aa_mutation":"p.ETV6::NTRK3",
        "disease":"Breast Secretory Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Larotrectinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:29623306"
    },
    {
        "gene_name":"BRCA2",
        "genomic_position":"13:32889617-32973805(+)",
        "cds_mutation":"unspecified_and_ERBB2_unspecified",
        "aa_mutation":"unspecified_and_ERBB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"BRCA2",
        "genomic_position":"13:32889617-32973805(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Triple-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"BRCA2",
        "genomic_position":"13:32889617-32973805(+)",
        "cds_mutation":"Loss-of-function",
        "aa_mutation":"Loss-of-function",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"BRCA2",
        "genomic_position":"13:32889617-32973805(+)",
        "cds_mutation":"Loss-of-function",
        "aa_mutation":"Loss-of-function",
        "disease":"Her2-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"BRCA2",
        "genomic_position":"13:32889617-32973805(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"BRCA2",
        "genomic_position":"13:32889617-32973805(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1380T>A",
        "aa_mutation":"p.N460K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.963T>A",
        "aa_mutation":"p.N321K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1296T>A",
        "aa_mutation":"p.N432K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1299T>A",
        "aa_mutation":"p.N433K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1647T>A",
        "aa_mutation":"p.N549K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1641T>A",
        "aa_mutation":"p.N547K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1383T>A",
        "aa_mutation":"p.N461K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1311T>A",
        "aa_mutation":"p.N437K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1650T>A",
        "aa_mutation":"p.N550K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1305T>A",
        "aa_mutation":"p.N435K",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.839T>A",
        "aa_mutation":"p.V280D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.842T>A",
        "aa_mutation":"p.V281D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.917T>A",
        "aa_mutation":"p.V306D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.848T>A",
        "aa_mutation":"p.V283D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.500T>A",
        "aa_mutation":"p.V167D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.939+4759T>A",
        "aa_mutation":"p.?",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1187T>A",
        "aa_mutation":"p.V396D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.920T>A",
        "aa_mutation":"p.V307D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1184T>A",
        "aa_mutation":"p.V395D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1190T>A",
        "aa_mutation":"p.V397D",
        "disease":"ER-positive_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1296T>A",
        "aa_mutation":"p.N432K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1380T>A",
        "aa_mutation":"p.N460K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1299T>A",
        "aa_mutation":"p.N433K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1647T>A",
        "aa_mutation":"p.N549K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1650T>A",
        "aa_mutation":"p.N550K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1305T>A",
        "aa_mutation":"p.N435K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1641T>A",
        "aa_mutation":"p.N547K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1311T>A",
        "aa_mutation":"p.N437K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.963T>A",
        "aa_mutation":"p.N321K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1383T>A",
        "aa_mutation":"p.N461K",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1611G>A",
        "aa_mutation":"p.M537I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1344G>A",
        "aa_mutation":"p.M448I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1605G>A",
        "aa_mutation":"p.M535I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1614G>A",
        "aa_mutation":"p.M538I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1275G>A",
        "aa_mutation":"p.M425I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1269G>A",
        "aa_mutation":"p.M423I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1260G>A",
        "aa_mutation":"p.M420I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1347G>A",
        "aa_mutation":"p.M449I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.1263G>A",
        "aa_mutation":"p.M421I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"FGFR2",
        "genomic_position":"10:123239371-123357917(-)",
        "cds_mutation":"c.927G>A",
        "aa_mutation":"p.M309I",
        "disease":"ductolobular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Endocrine therapy",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32723837"
    },
    {
        "gene_name":"MMP2",
        "genomic_position":"16:55512883-55540603(+)",
        "cds_mutation":"SERUM_LEVELS",
        "aa_mutation":"SERUM_LEVELS",
        "disease":"Inflammatory Breast Carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Bevacizumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26921265"
    },
    {
        "gene_name":"TOP2A",
        "genomic_position":"17:38544768-38574202(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Doxorubicin",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:15486187"
    },
    {
        "gene_name":"F2",
        "genomic_position":"11:46740730-46761056(+)",
        "cds_mutation":"K159fs",
        "aa_mutation":"p.K159fs",
        "disease":"Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Temsirolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25878190"
    },
    {
        "gene_name":"CDK6",
        "genomic_position":"7:92234235-92463231(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27252418"
    },
    {
        "gene_name":"CDK6",
        "genomic_position":"7:92234235-92463231(-)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Estrogen-receptor Positive Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27252418"
    },
    {
        "gene_name":"AKT1",
        "genomic_position":"14:105235686-105260461(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Capivasertib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26351323"
    },
    {
        "gene_name":"AKT1",
        "genomic_position":"14:105235686-105260461(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capivasertib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26351323"
    },
    {
        "gene_name":"AKT1",
        "genomic_position":"14:105235686-105260461(-)",
        "cds_mutation":"unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified",
        "aa_mutation":"unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capivasertib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26351323"
    },
    {
        "gene_name":"AKT1",
        "genomic_position":"14:105235686-105260461(-)",
        "cds_mutation":"unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified",
        "aa_mutation":"unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capivasertib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26351323"
    },
    {
        "gene_name":"AKT1",
        "genomic_position":"14:105235686-105260461(-)",
        "cds_mutation":"c.49G>A",
        "aa_mutation":"p.E17K",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capivasertib",
        "description":null,
        "rs_value":121434592.0,
        "pmid":"PubMed:26351323"
    },
    {
        "gene_name":"AKT1",
        "genomic_position":"14:105235686-105260461(-)",
        "cds_mutation":"unspecified_or_ATM_unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRCA1_unspecified_or_BRCA2_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_undefined_or_FANCD2_undefined_or_FANCE_undefined_or_FANCF_undefined_or_FANCG_undefined_or_FANCL_undefined_or_MRE11_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
        "aa_mutation":"unspecified_or_ATM_unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRCA1_unspecified_or_BRCA2_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_undefined_or_FANCD2_undefined_or_FANCE_undefined_or_FANCF_undefined_or_FANCG_undefined_or_FANCL_undefined_or_MRE11_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capivasertib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26351323"
    },
    {
        "gene_name":"AKT1",
        "genomic_position":"14:105235686-105260461(-)",
        "cds_mutation":"c.49G>A",
        "aa_mutation":"p.E17K",
        "disease":"Breast Cancer",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Capivasertib",
        "description":null,
        "rs_value":121434592.0,
        "pmid":"PubMed:26351323"
    },
    {
        "gene_name":"F3",
        "genomic_position":"1:94994781-95007356(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Dovitinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23658459"
    },
    {
        "gene_name":"F3",
        "genomic_position":"1:94994781-95007356(-)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Dovitinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23658459"
    },
    {
        "gene_name":"LAT",
        "genomic_position":"16:28996147-29002104(+)",
        "cds_mutation":"PHOSPHORYLATION",
        "aa_mutation":"p.PHOSPHORYLATION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Alpelisib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25002028"
    },
    {
        "gene_name":"MMP9",
        "genomic_position":"20:44637547-44645200(+)",
        "cds_mutation":"SERUM_LEVELS",
        "aa_mutation":"SERUM_LEVELS",
        "disease":"Inflammatory Breast Carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Bevacizumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26921265"
    },
    {
        "gene_name":"ETV6",
        "genomic_position":"12:11802788-12048336(+)",
        "cds_mutation":"ETV6::NTRK3",
        "aa_mutation":"p.ETV6::NTRK3",
        "disease":"Breast Secretory Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Larotrectinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:29623306"
    },
    {
        "gene_name":"RSF1",
        "genomic_position":"11:77371041-77532063(-)",
        "cds_mutation":"Amplification",
        "aa_mutation":"Amplification",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:24367492"
    },
    {
        "gene_name":"C5",
        "genomic_position":"9:123714616-123812554(-)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Her2-receptor Positive Breast Cancer",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Trastuzumab",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:23204226"
    },
    {
        "gene_name":"AGR2",
        "genomic_position":"7:16831435-16844704(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Resistance",
        "therapies":"Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:24167368"
    },
    {
        "gene_name":"TF",
        "genomic_position":"3:133464800-133497850(+)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Aminoglutethimide,Tamoxifen",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25900183"
    },
    {
        "gene_name":"CA2",
        "genomic_position":"8:86376081-86393722(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Triple-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"CA2",
        "genomic_position":"8:86376081-86393722(+)",
        "cds_mutation":"Loss-of-function",
        "aa_mutation":"Loss-of-function",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"CA2",
        "genomic_position":"8:86376081-86393722(+)",
        "cds_mutation":"Loss-of-function",
        "aa_mutation":"Loss-of-function",
        "disease":"Her2-receptor Negative Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"CA2",
        "genomic_position":"8:86376081-86393722(+)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Breast Cancer",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:28792849"
    },
    {
        "gene_name":"CDK4",
        "genomic_position":"12:58141510-58146304(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Erdafitinib + Fulvestrant + Palbociclib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03238196"
    },
    {
        "gene_name":"BARD1",
        "genomic_position":"2:215590370-215674428(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Talazoparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04892693"
    },
    {
        "gene_name":"AR",
        "genomic_position":"X:66764465-66950461(+)",
        "cds_mutation":"unspecified_and_ERBB2_unspecified",
        "aa_mutation":"unspecified_and_ERBB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Aromatase inhibitors + Bicalutamide",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02910050"
    },
    {
        "gene_name":"AR",
        "genomic_position":"X:66764465-66950461(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Aromatase inhibitors + Bicalutamide",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02910050"
    },
    {
        "gene_name":"AR",
        "genomic_position":"X:66764465-66950461(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Aromatase inhibitors + Bicalutamide",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02910050"
    },
    {
        "gene_name":"AR",
        "genomic_position":"X:66764465-66950461(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Aromatase inhibitors + Bicalutamide",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02910050"
    },
    {
        "gene_name":"AR",
        "genomic_position":"X:66764465-66950461(+)",
        "cds_mutation":"unspecified_or_PTEN_unspecified",
        "aa_mutation":"unspecified_or_PTEN_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Aromatase inhibitors + Bicalutamide",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02910050"
    },
    {
        "gene_name":"AR",
        "genomic_position":"X:66764465-66950461(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Aromatase inhibitors + Bicalutamide",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02910050"
    },
    {
        "gene_name":"AR",
        "genomic_position":"X:66764465-66950461(+)",
        "cds_mutation":"unspecified_and_ERBB2_unspecified",
        "aa_mutation":"unspecified_and_ERBB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Aromatase inhibitors + Bicalutamide",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02910050"
    },
    {
        "gene_name":"AR",
        "genomic_position":"X:66764465-66950461(+)",
        "cds_mutation":"unspecified_and_ESR1_unspecified",
        "aa_mutation":"unspecified_and_ESR1_unspecified",
        "disease":"breast | carcinoma | ER-positive carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Aromatase inhibitors + Bicalutamide",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02910050"
    },
    {
        "gene_name":"EGFR",
        "genomic_position":"7:55086794-55279321(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Gefitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT01732276"
    },
    {
        "gene_name":"EGFR",
        "genomic_position":"7:55086794-55279321(+)",
        "cds_mutation":"unspecified_and_ERBB2_unspecified",
        "aa_mutation":"unspecified_and_ERBB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Gefitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT01732276"
    },
    {
        "gene_name":"EGFR",
        "genomic_position":"7:55086794-55279321(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Gefitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT01732276"
    },
    {
        "gene_name":"EGFR",
        "genomic_position":"7:55086794-55279321(+)",
        "cds_mutation":"unspecified_or_ERBB2_unspecified",
        "aa_mutation":"unspecified_or_ERBB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Gefitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT01732276"
    },
    {
        "gene_name":"EGFR",
        "genomic_position":"7:55086794-55279321(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Gefitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT01732276"
    },
    {
        "gene_name":"ATM",
        "genomic_position":"11:108093559-108239826(+)",
        "cds_mutation":"unspecified_or_ATR_unspecified_or_BAP1_unspecified_or_BARD1_unspecified_or_BLM_unspecified_or_BRIP1_unspecified_or_CHEK1_unspecified_or_CDK12_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCM_unspecified_MRE11_unspecified_or_NBN_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified_or_WRN_unspecified",
        "aa_mutation":"unspecified_or_ATR_unspecified_or_BAP1_unspecified_or_BARD1_unspecified_or_BLM_unspecified_or_BRIP1_unspecified_or_CHEK1_unspecified_or_CDK12_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCM_unspecified_MRE11_unspecified_or_NBN_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified_or_WRN_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05033756"
    },
    {
        "gene_name":"ATM",
        "genomic_position":"11:108093559-108239826(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05033756"
    },
    {
        "gene_name":"ATM",
        "genomic_position":"11:108093559-108239826(+)",
        "cds_mutation":"unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRCA1_unspecified_or_BRCA2_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCM_unspecified_or_MRE11A_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
        "aa_mutation":"unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRCA1_unspecified_or_BRCA2_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCM_unspecified_or_MRE11A_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05033756"
    },
    {
        "gene_name":"ATM",
        "genomic_position":"11:108093559-108239826(+)",
        "cds_mutation":"unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCG_unspecified_or_FANCL_unspecified_or_MRE11_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_RAD51D_unspecified",
        "aa_mutation":"unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCG_unspecified_or_FANCL_unspecified_or_MRE11_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_RAD51D_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05033756"
    },
    {
        "gene_name":"ATM",
        "genomic_position":"11:108093559-108239826(+)",
        "cds_mutation":"unspecified_or_BARD1_unspecified_or_CHEK2_unspecified_or_FANCC_unspecified_or_PALB2_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified_or_SLX4_unspecified_or_XRCC2_unspecified",
        "aa_mutation":"unspecified_or_BARD1_unspecified_or_CHEK2_unspecified_or_FANCC_unspecified_or_PALB2_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified_or_SLX4_unspecified_or_XRCC2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Olaparib + Pembrolizumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05033756"
    },
    {
        "gene_name":"CHEK2",
        "genomic_position":"22:29083751-29137826(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"VEGFA",
        "genomic_position":"6:43738444-43752346(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Vandetanib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02299999"
    },
    {
        "gene_name":"PPP2R2A",
        "genomic_position":"8:26150732-26228402(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Talazoparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04892693"
    },
    {
        "gene_name":"ERBB3",
        "genomic_position":"12:56473645-56497289(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Patritumab deruxtecan",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02980341"
    },
    {
        "gene_name":"CCR5",
        "genomic_position":"3:46411633-46417673(+)",
        "cds_mutation":"unspecified_and_CD274_unspecified",
        "aa_mutation":"unspecified_and_CD274_unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Leronlimab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03838367"
    },
    {
        "gene_name":"CHEK1",
        "genomic_position":"11:125496236-125527031(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Talazoparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04892693"
    },
    {
        "gene_name":"FGFR3",
        "genomic_position":"4:1795039-1810599(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Futibatinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04024436"
    },
    {
        "gene_name":"TACSTD2",
        "genomic_position":"1:59041099-59043166(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Sacituzumab govitecan",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05332561"
    },
    {
        "gene_name":"ERBB4",
        "genomic_position":"2:212240446-213403565(-)",
        "cds_mutation":"unspecified_and_CD274_unspecified",
        "aa_mutation":"unspecified_and_CD274_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Cyclophosphamide + Docetaxel + Epirubicin hydrochloride + Nab-paclitaxel + Pyrotinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04872985"
    },
    {
        "gene_name":"ERBB4",
        "genomic_position":"2:212240446-213403565(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Cyclophosphamide + Docetaxel + Epirubicin hydrochloride + Nab-paclitaxel + Pyrotinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04872985"
    },
    {
        "gene_name":"ERBB4",
        "genomic_position":"2:212240446-213403565(-)",
        "cds_mutation":"unspecified_and_CD274_unspecified",
        "aa_mutation":"unspecified_and_CD274_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Cyclophosphamide + Docetaxel + Epirubicin hydrochloride + Nab-paclitaxel + Pyrotinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04872985"
    },
    {
        "gene_name":"MAP2K1",
        "genomic_position":"15:66679155-66784650(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"PD0325901",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22402123"
    },
    {
        "gene_name":"MAP2K1",
        "genomic_position":"15:66679155-66784650(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.L115P",
        "disease":"NS",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"PD0325901",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22402123"
    },
    {
        "gene_name":"CDK12",
        "genomic_position":"17:37618292-37691399(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Talazoparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04892693"
    },
    {
        "gene_name":"RAD54L",
        "genomic_position":"1:46713404-46744144(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Talazoparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04892693"
    },
    {
        "gene_name":"ALK",
        "genomic_position":"2:29415640-30144432(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Crizotinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02034981"
    },
    {
        "gene_name":"BCL2",
        "genomic_position":"18:60790579-60987361(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Letrozole + Palbociclib + Venetoclax",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03900884"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Avelumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02926196"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified_and_ERBB2_unspecified",
        "aa_mutation":"unspecified_and_ERBB2_unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Avelumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02926196"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Avelumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02926196"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Avelumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02926196"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Avelumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02926196"
    },
    {
        "gene_name":"NF1",
        "genomic_position":"17:29421945-29704695(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Famitinib + SHR7390",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04355858"
    },
    {
        "gene_name":"RAD51B",
        "genomic_position":"14:68286525-69062713(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Talazoparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04892693"
    },
    {
        "gene_name":"ROS1",
        "genomic_position":"6:117609463-117747018(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Crizotinib + Fulvestrant",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03620643"
    },
    {
        "gene_name":"FANCL",
        "genomic_position":"2:58386382-58468485(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Talazoparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04892693"
    },
    {
        "gene_name":"MTOR",
        "genomic_position":"1:11166592-11322564(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Rapamycin",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27279227"
    },
    {
        "gene_name":"MTOR",
        "genomic_position":"1:11166592-11322564(-)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.F2108L",
        "disease":"NS",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Rapamycin",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:27279227"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Lenvatinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03168074"
    },
    {
        "gene_name":"WT1",
        "genomic_position":"11:32409321-32457176(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Galinpepimut-S + Pembrolizumab + Sargramostim",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03761914"
    },
    {
        "gene_name":"WT1",
        "genomic_position":"11:32409321-32457176(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Galinpepimut-S + Pembrolizumab + Sargramostim",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03761914"
    },
    {
        "gene_name":"RAD51D",
        "genomic_position":"17:33427691-33446832(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"PDGFRB",
        "genomic_position":"5:149493400-149535423(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Famitinb",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04355858"
    },
    {
        "gene_name":"NT5E",
        "genomic_position":"6:86159809-86205496(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | basal (triple-negative) carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Carboplatin + Durvalumab + Oleclumab + Paclitaxel",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03616886"
    },
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Paclitaxel + Pelareorep",
        "description":null,
        "rs_value":null,
        "pmid":"Corporate website:NCT01656538"
    },
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Paclitaxel + Pelareorep",
        "description":null,
        "rs_value":null,
        "pmid":"Corporate website:NCT01656538"
    },
    {
        "gene_name":"RAD51C",
        "genomic_position":"17:56769934-56811703(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"BRIP1",
        "genomic_position":"17:59758627-59940882(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Talazoparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04892693"
    },
    {
        "gene_name":"PALB2",
        "genomic_position":"16:23614491-23652631(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"breast | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Capecitabine + Platinum-based chemotherapy",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT04335669"
    },
    {
        "gene_name":"MAP2",
        "genomic_position":"2:210444145-210598842(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.L115P",
        "disease":"NS",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"PD0325901",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22402123"
    },
    {
        "gene_name":"MET",
        "genomic_position":"7:116312459-116436396(+)",
        "cds_mutation":"c.3682G>A",
        "aa_mutation":"p.D1228N",
        "disease":"basal_(triple-negative)_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Crizotinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32234363"
    },
    {
        "gene_name":"MET",
        "genomic_position":"7:116312459-116436396(+)",
        "cds_mutation":"c.3736G>A",
        "aa_mutation":"p.D1246N",
        "disease":"basal_(triple-negative)_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Crizotinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:32234363"
    }
]